Sanginita Chemicals Limited (SANGINITA) Fair Value & Analysis
Basic Materials · IN · Market cap ₹1.2B
Fair value as of: Jul 3, 2026
From 9 valuation models · updated today
Share price +51.0% over the past month.
Price vs Fair Value (12 months)
12‑month range ₹9.40 – ₹45.85 · fair‑value band ₹42.23 – ₹82.47 · the ₹45.85 price screens below the ₹62.35 fair value. As of Jul 3, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
Sanginita Chemicals Limited (SANGINITA) currently trades at ₹45.85, while our model-based Fair Value estimate is ₹62.35 — implying the stock looks roughly 36.0% undervalued today. We read business quality at 60/100 (solid quality), in the Basic Materials sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium) — always confirm before acting.
Over the trailing twelve months, Sanginita Chemicals Limited generated revenue of ₹1.8B at a net margin of -5.5%. Revenue declined 13.8% year over year. It earns a return on equity of -18.9%. Net debt stands at ₹122M. Fundamentals as of Jul 3, 2026
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jul 3, 2026. TTM = trailing twelve months.
About the company
Sanginita Chemicals Limited manufactures and sells cuprous chloride, cupric chloride, and copper sulphate in India and internationally. It also offers copper phthalocyanine blue. The company's products are used in dyes and pigments, paint, pharmaceuticals, electroplating, metal extraction and ink, carbon paper, and PVC pipe coating industries. It also exports its products. The company was founded in 2003 and is based in Gandhinagar, India.
Revenue & earnings trend
FY2022 – FY2026 · reported fiscal years
Sanginita Chemicals Limited reported revenue of ₹1.8B in FY2026 versus ₹2.0B in FY2022, a compound −2.8%/yr. Reported net income was −₹96.9M in FY2026.
Is SANGINITA fairly valued? → Check now
Similar stocks
6 more Chemicals stocks, each showing price versus our Fair Value estimate (as of Jul 3, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Linde plc LIN | €425.60 | €106.89 | -75% |
| Shin-Etsu Chemical Co SHECY | $22.43 | $14.26 | -36% |
| BASF SE BAS | €47.98 | €23.76 | -50% |
| Ningxia Baofeng Energy Group 600989 | ¥21.72 | ¥42.42 | +95% |
| Dow Inc D1OW34 | R$41.12 | R$16.66 | -59% |
| Ganfeng Lithium Group 002460 | ¥72.05 | ¥21.69 | -70% |
Explore undervalued stocks
More undervalued Basic Materials stocks →
Frequently asked questions
Is Sanginita Chemicals Limited (SANGINITA) undervalued?
What is the fair value of SANGINITA?
What is the quality score of SANGINITA?
What is the revenue of Sanginita Chemicals Limited (SANGINITA)?
What is the net profit margin of SANGINITA?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.